Moderna(MRNA)公司今日夜盘大跌5.24%,引发市场广泛关注。消息人士透露,这与特朗普政府有意撤销对Moderna公司禽流感疫苗开发的5.9亿美元资助有关。
根据彭博社的报道,美国卫生官员当前正在重新评估去年1月份授予Moderna公司的这笔大额疫苗合同。一旦撤销,将严重影响Moderna在禽流感疫苗领域的未来发展,市场对该公司长期增长潜力的信心也将受到打击。
分析人士指出,这一举措与新任卫生部长罗伯特·F·肯尼迪对新冠疫苗持怀疑态度有关,也是拜登政府推动审查基于mRNA技术的疫苗支出的一部分。新冠肺炎疫情结束后,公众对疫苗接种的关注度正在下降,政府也将资金转向其他领域。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.